-
CDC. 1998 Guidelines for
treatment of sexually transmitted diseases. MMWR l998;47(No. RR-I).
-
CDC. Hepatitis Â
virus: a comprehensive strategy for elirninatiitg transmission in the
United States through universal childhood vaccination— recommendations
of the Immunization Practices Advisory Committee (ACIP). MMWR l99l;40(No.
RR-13).
-
CDC. Prevention of
hepatitis A through aci.ve or passive immunization: recommendations of
the Advisory Committee on Immunization Practices (ACIP). MMJVR 1999;48(No.
RR-12).
-
Hatcher RA, Trussell TJ,
Stewart FH, et at., eds. Contraceptive technology.
17th ed. New York: Ardent Media, 1998.
-
Drew WL, Blair M, Miner RC,
Conant M. Evaluation of the virus permeability of a new condom for women.
Sex Transm Dis 1990; 17:110-2.
-
Richardson BA. Nonoxynol-9 as
a vaginal mircrobicide for prevention of sexually transmitted infections.
JAMA 2002:287:1171-2.
-
Gates W, Stone KM. Family
planning, sexually transmitted diseases, and contraceptive choice: a
literature update—part 1. Farn Plann Perspectives 1992:24:74-84.
-
CDC. Revised guidelines for
HIV counseling, testing, ana referral and revised recommendations for HIV
screening of pregnant women. MMWR200l:50(No. RR-19): 13-26.
-
Kamb ML, Fishbein M, Douglas
JM, et al. Í1Ó
prevention counseling reduces high risk behaviors and sexually
transmitted diseases'. results from a multicenter, randomized controlled
trial (Project RESPECT). JAMA 1998:280:1161-7.
-
U.S. Preventive Services Task
Force. Guide to clinical preventive services. 2nd ed. Baltimore, MD:
Williams & Wilkins, 1996.
-
American Academy of Pediatrics
and American College of Obstetricians and Gynecologists. Guidelines for
perinatal care. 4th ed. Washington. DC: American Academy of Pediatrics
and American College of Obstetricians and Gynecologists, 1997.
-
American College of
Obstetricians and Gynecologists. Antimic robial therapy for obstetric
patients. Washington, DC: American College of Obstetricians and
Gynecologists, March 1998. (Educational bulletin, no. 245.)
-
American College of
Obstetricians and Gvnecologists. Committee opin- ion: primary and
preventive care. Washington. DC: American College of Obstetricians find
Gyneci/iogist\, December 1999. (Penodic assessments, no. 229.)
-
CDC. Recommendations for the
prevention and management of Chlamydiatrachomatis infections. 1993.
MMWR. 1993;42(No. RR-12).
-
Zanetti AR, Tanzi E, Ne\\ell
ML. Mother-to- in/am transmission .hepatitis Ñ
virus. J Hepatol 1999:3! (Suppl):96-l 00.
-
Burns DN, Minkoff H. Hepatitis
C: screening in pregnancy Obsiel Gynecol 1999:94:1044.
-
American College of
Obstetricians and Gynecologists. Viral hepatitis in pregnancy. Washington,
DC: American College of Obstetricians and Gynecologists, July 1998. (Educational
bulletin, no. 248.)
-
American Academy of Pediatrics
and American College of Obstetricians and Gynecologists. Human
immunodeficiency virus screening' joint statement of the AAP and AGOG.
Pediatrics 1999:104:128.
-
Institute of Medicine.
Reducing the odds: preventing perinatal transmission of HIV in the
United States. Washington, DC: National Academy Press, 1999.
-
CDC. Revised US
Public Health Service recommendations for human immunodeficiency virus
screening of pregnant women. MMWR2001;50(No. RR-I9):59-86.
-
CDC. USPHS/IDSA Prevention of
Opportunistic Infections Working Group. 2001 USPHS/JDSA guidelines for
the prevention of opportunistic infections in persons infected
wth human immunodeficiency virus. Atlanta, GA: US Department of Health
and Human Services, Centers for Disease Control and Prevention, November
28, 2001. Available al http://www.hivatis.org.
-
CDC. Testing for antibodies to
human immunodeficiency virus type 2 in the United States. MMWR (in press).
-
Department of Health and Human
Services, H"nry J. Kaiser Foundation Panel on Clinical Practices
for the Treatment of HIV Infection. Guidelines for the use of
antiretroviral agents in HIV-infected adults and adolescents. US
Department of Health and Human Services, February 4, 2002. Available at
hitp./Avvr'w.hivatis.org.
-
Carpenter CJ. Cooper
DA, Fi^cbi ÛÀ, et u\.
An'tire'lroviral therapy ò adults
updated recommendations of the International AIDS Society- " USA
Panel JAMA 2000,283 381-90
-
CDC CDC National Prevention
Plan Federal Register 2002 (in press)
-
CDC Prevention and treatment
of tuberculosis among patients infected with human immunodeficiency virus
principles of therapy and revised recommendations MMWR 1998 47 (No RR-20)
-
CDC HIV Prevention case
management guidance Atlanta GA US Department of Health and Human Services,
Public Health Service, September 1997
-
Fowler MG, Simonds RJ,
Roongpisuthipong A Update on perinatal HIV transmission Pediatr Clin North
Am 2000,47 241-60
-
CDC Recommendations for the øå
of antiretroviral drugs in pregnant HIV-1 infected women for maternal
health and interventions to reduce perinatal HIV-1 transmission in the
United States Atlanta, GA US Department of Health and Human Services,
February' 4 2002 Available at http //wwwhivatis org
-
CDC Guidelines for the use
of'antiretroviral agents in pediatnc HIV infection Atlanta, GA US
Department of Health and Human Services, August 8, 2001 Available at http
ffwww hivatis org
-
Wald A New therapies
and prevention strategies for genital herpes Clin Infect Dis 1999.28(Suppl)
S4-S13
-
Bodsworth NJ, Crooks RJ,
Borelli S, et al Valaciclovir versus acyclovir in patient-initiated
treatment of genital herpes a randomized, double-blind clinical trial
Gemtounn Med 1997 73 110-6
-
Patel R, Bodsworth NJ, Wooley
P, et al Valaciclovir for the suppression of recurrent genital HSV
infection a placebo controlled study of once-daily therapy Gemtounn Med
1997,73 105-9
-
Spruance S, Trying S,
Degregono Â, Miller Ñ,
Beutner Ê, the Valaciclovir HSV
Study Group A large-scale, placebo-controlled, dose-ranging trial
ofperoral valacyclovirfor episodic treatment of recurrent herpes genitalis
Arch Int Med 1996,156 1729-35
-
Fife ÊÍ.
Barbarash RA, Rudolph Ò,
Degregono Â, Roth RE Valaciclovir
versus acyclovir in the treatment of first-episode genital herpes
infection results of an international, multicenter, double-blind
randomized clinical trial Sex Transm Dis 1997,24 481-6
-
Reitano M, Tyring S, bang W,
et al Valaciclovirfor the suppression of recurrent genital herpes simplex
virus infection a large-scale dose range-finding study J Infect Dis 1998
178 603-10
-
Chosidow 0, Drouault Y,
Lecontae- Veynac F, et al Famciclo\ir vs aciclovir in immunocompetent
patients with recurrent genital herpes infections a parallel-groups,
randomized, double-blind clinical trial Br J Dermatol 2001 144 818-24
-
Diaz-Mitoma F. Sibbald RG,
Shafran SD, Boon R, Saltzman RL Oral famciclovir for the suppression of
recurrent genital herpes a randomized controlled trial JAMA 1998,280887-92
-
Loveless M, Harris W, Sacks S
Treatment of first episode genital herpes with famciclovir In Programs and
abstracts of the 35th Interscience Conference on Antimicrobial Agents and
Chemotherapy, San Francisco, California, 1995
-
Mertz GJ, Loveless ÌÎ,
Levin MJ et al Oral famciclovir for suppression of recurrent genital
herpes simplex virus infection in women a multicenter, double-blind,
placebo-controlled trial Arch Intern Med 1997.157 343-9
-
Sacks SL. Aoki FY, Diaz-Mitoma
F. Sellers J Shafran SD Patient-initiated, twice-daily oral famciclovir
for early recurrent genital herpes a randomized, double-blind
multicenter trial JAMA 1996 276 44-9
-
Henry RE, WegmannJA HartleJE,
Christopher GW Successful oral acyclovir desensitization Ann Allergy 1993
70386—8
-
Reiff-Eldndge RA, Heffner CR,
Ephross SA, Tennis PS, White AD, Andrews EB Monitoring pregnancy outcomes
after prenatal drug exposure through prospective pregnancy registries a
pharmaceutical company commitment Am J Obstet Gynecol 2000, 182 159—63
-
Scott LL, Sanchez PJ, Jackson
GL, Zeray F, Wendel GD, Jr Acyclovir suppression to prevent cesarean
delivery after first-episode genital herpes Obstet Gynecol 1996,87 69-73
-
Brocklehurst P, Kinghom G,
Camey 0, et al A randomised placebo controlled trial of suppressive
acylovir in late pregnancy in women with recurrent genital herpes
infection Br J Obstet Gynaecol 1998 105 275-80
-
Thorpe ÅÌ,
Stamm WE, Hook EW, et al Chlamydial cervic itis and urethntis single dose
treatment compared with doxycycline for seven days in community-based
practices Gemtounn Med 1996 72 93-7
-
Stamm WE, Hicks CB, Martin DH,
et al Azithromycin for empirical treatment of the nongonococcal urethntis
syndrome in men a randomized double-blind study JAMA 1995 274 545-9
-
Adair CD, GunterM, Stovall TG,
McElvoy G, VeilleJC. ErmentJM Chlamydia in pregnancy a randomized
trial of azithromycin and enthromycin Obstet Gynecol 1998 91 165-8
-
Wehbeh ÍÀ,
Ruggeino RM, Shakem S, Lopez G, All Y Single dose azithromycin for
chlamydia in pregnant women J Reprod Med 1998 43 509-14
-
MoranJS, Levine WC
Drugs of choice for the treatment of uncomplicated gonococcal infections
Clin Infect Dis 1995,20(Suppl 1),S47—S65
-
Haimovici R, Rous'selTJ
Treatment of gonococcal conjunctivitis with single-dose intramuscular
ceftnaxone Am J Ophthalmol 1989 107 511
-
Hauth JC, Goldenberg RL.
Andrews WW, DuBard MB, Copper RL Reduced incidence ofpreterm delivery with
metromdazole and eryth-romycin in women with bacterial vaginosis N Engi J
Med 1995 333 1732-6
-
Morales WJ Schorr S, Albntton
J Effect of metromdazole in patients with preterm birth in preceding
pregnancy and bacterial vaginosis a placebo-controlled, double-blind study
'Am J Obstet Gynecol 1994 171 345-9
-
McDonald ÈÌ,
O'LoughlinJA, Vigneswaran R, etal Impact of metromdazole thei àðó
on preterm birth in women with bacterial vaginosis flosa (Gardnerella
vagmalis) a randomised, placebo controlled trial BrJObslet Gynaecol
1997 104 1391-7
-
Jack&on P, Rid ley WJ,
Pattison NS Single dose metromdazole prophylaxis in gynaecological surgery
NZ Med J 1979 89 243-5
-
WillisAT Metromdazole in the
prevention and treatment of Bacleroides infections in gynaecological
patients Lancet 1974,2 1540-3
-
PerssonE, BergstromM, LarswnPG,
etal Infections after hysterec-tomv è
prospective nationw ide Swedish Study Acta Obstetnca et Gynecologiaca
Scandinavica 1996 75 757-61
-
Larsson PG, Platz-Chnstenven
JJ, Forsum U, Pahlson Ñ Clue
cells in predicting infections after abdominal hysterectomy Obstet Gynecol
1991,77 450-2
-
Newton ER Pnhoda TJ. Gibbs RS
A clinical and microbiologic analysis of risk factors for puerperal
endotnetntis Obstet Gynecol 1990 75 402-6
-
Soper DE, Bump RC, Hurt WG
Bacterial vaginosis and Inc ho manias i1,
agimtiv are rifk factors fui cuff ceilulitis after abdominal h steiectomy
Am] Obstet Gynecol /990,163 1016-21
-
Watts DH Krohn MA, Hillier SL,
Eschenbach DA Bacterial vaginosis à÷
a risk factor for post-f å÷àãåàï
endometnti ? Obstet Gynecol 1990 75 52-8
-
Sihcr HM, SperiingRS Sf Glair
PJ, Gibbs RS Evidence relating bacterial vaginow þ
inti aammotic infection Am J Obstet Gynecol 1989 161 808-12
-
B/ornerem A, Aghajam E
MaltauJM.MoiH Occurrence of bacterial vagino4is among abortion seekers
Tidssknft for Den Norske Laegeforemng 1997, i 17 1282-4
-
Hamark Â,
Foreman L Postabortal endometntis in chlamydia-negative women-association
with preoperative clinical signs of infection Gvnecol Obstet Invest 1991
31 102-5
-
Lars ÷îï
PG, Bergman  fo! sum U,
Platz-Chnstensen JJ, Pahlson Ñ
Mobiluncus and clue cells as predictors ofPID after first-trimester
abortion Acta Obstetnca ei Gvnecologica Scandinavica 1989 68 217-20
-
Hillier SL, Marcus J, Krohn M,
Kiviat N, Holmes KK, Eschenbach DA A case-control study of chonoammomc
infection and histologic chorioamniomti4 in prematurity New Engi J Med
1998 319 972-8
-
Livengood ÑÍ,
Ø, Super DE, Sheehan KL, et al
Companson of once-daily and twice-daily dosing ofO 75% metromdazole gel in
the treatment of bacterial vaginosis Sex Transm Dis 1999,26 137—42
-
Sobel J Peipert JF, McGregor
JA, et al Efficacy of clindamycin vaginal ovule vs clindamycin vaginal
cream in bacterial vaginosis Infect Dis Obfitet Gynecol 2002 (in press}
-
Moi H, Erkkola R, Jerve F, et
al Should male consorts of women with bacterial vaginosiv be treated9
Gemtounn Med 1989 65 263—8
-
Colli E Landoni M, Parazzim F,
et al Treatment of male partners and recurrence of bacterial vaginosis a
randomised trial Gemtounn Med 1997 73 267-70
-
VejtorpM.BollcrupAC.VejtorpL,
etal Bacterial vaginosis adouble-blind randomized trial of the effect of
treatment of the sexual partner BrJ Obstet Gynaecol 1988 95 920-6
-
McGregor JA, French Jl, Jones
W, et al Bacterial vaginosis is associated with prematurity and vaginal
fluid mucinase andsialidase results of a controlled trial of topical
clindamycin cream Am J Obstet Gynecol 1994 170 1048-59
-
JoesoefMR, Hilher SL,
Wihyosastro G, et al Intravagmal chndamycin treatment for bacterial
vaginosis effects on preterm delivery and low birth weight Am J Obstet
Gynecol 1995 173 1527-31
-
Vermeulen GM, Bruinse HW
Prophylactic administration of chndamycin 2% vaginal cream to reduce the
incidence of spontaneous preterm birth in women with an increased
recurrence risk a randomised placebo-controlled double-blind ti lal Br J
Obstet Gynaecol 1999 106 652-7
-
Caro-Paton T, Carvajal A
Martin de Diego I Maitin-Anas LH, Alvarez Requejo A Is metromdazole
teratogemc/>
A meta-analysis BrJClin Pharmacol 1997 44 179-82
-
Burtin P, Taddio A, Anburnu Î
Einarwn TR Koren G Safety of metromdazole in pregnancy a meta-analysis Am
J Obstet Gynecol 1995,172 525-9
-
Piper JM, Mitchel Ef, Ray WA
Prenatal use of metromdazole and birth defects no association Obstet
Gynecol 1993,82 348-52
-
Carey JC, KlebanoffMA, Hauth
JC et al Metronidazole to prevent preterm delivery in pregnant women with
asymptomatic bacterial vaginosis New Engi J Med 2000 342 534-40
-
Hay PE, Ugwumadii ANN, Jeffrey
I, Manvonda JT Oral chndamycin prevent'! spontaneous pretei ò
birth and mid trimester miscarriage in pregnant women with bacterial
vaginosis Int J STD AIDS 2001.12(Suppl2) 70-1
-
PearlmanMD, Yashaf C, Ernst S,
Solomon W An incremental dosing protocol for women with severe vaginal
tnchomoniasis and adverse reactions to metromdazole Am J Obstet Gynecol
1996, 174 934-6
-
KlebanoffMA, Caiev JC, Hauth
JC et al Failure of metromdazole to prevent preterm delivery among
pregnant women with asymptomatic Tnchomonas vagmalis infection New
Engi J Med 2001 345 487-93
-
Walker CK, Kahn JG, Washington
4E, Peterson HB, Sweet RL Pelvic inflammatory disease meta-analysis of
antimicrobial regimen efficacy J Infect Dis 1993,168 969-78
-
Matsuda S Clinical study of
levofloxacin (LVFX) on the infectious diseases in the field of obstetrics
and gynecology Chemotherapy 1992,40311-23
-
Martens MG, Gordon S,
Yarborough DR Faro S Binder D Berkeley A Multicenter randomized trial of
ofloxacin veisus cefoxitin and doxv-cycline in outpatient treatment of
pelvic inflammatory disease South MedJ 1993,86 604-10
-
PeipertJF, Sweet RL, Kahn J,
Reilly-Gauvin Ê Evaluation of
ofloxacin in the treatment of laparoscopically documented acute pelvic
inflammatory disease (salpingitis) Infect Dis Obstet Gynecol 1999,7 138-4
-
Walker CK, Workowski KA,
Washington AE Soper D, Sweet RL Anaerobes in pelvic inflammatory disease
implications for the Centers for Disease Control and Preventions
guidelines for treatment of sexually transmitted diseases dm Infect Dis
I999,28(Suppl 1) S29-S36
-
Witte EH, Peters AA, Smit IB
van der Linden MC, Mouton RP, van der Meer JW, van Erp EJ A comparison of
pefloxacin/metronidazole and doxycycline/metromdazole in the treatment of
laparoscopically confirmed acute pelvic inflammatory disease Eur J Obstet
Gynecol ReprodBiol 1993,50 153-8
-
Ridgway GL, Bevan C, Siddle N
Azithromycm with or without metromdazole compared with cefoxitin,
doxycycline and metromdazole in the treatment of laparoscopy confirmed
acute pelvic inflammatory disease [Abstract] In Proceedings of the llth
International Meeting of the International Society for STD Reseaich, New
Orleans Fort Lee, New Jersey International Society for STD Research, 1995-
-
Cohen CR, Sinei S, Reilly M,
et al Effect of human immunodeficiency virus type I infection upon acute
salpingitis a laparoscopic study J Infect Dis 1998.178 1352-8
-
Bukesi EA, Cohen CR, Stevens
CE et al Effects of human immunodeficiency virus 1 infection on
microbial origins of pelvic inflammatory disease and on efficacy of
ambulatory oral therapy Am J Obstet Gynecol 1999 18 1374-81
-
Irwin KL, Moorman AC, 0
Sullivan MJ et al Influence of human immunodeficiency virus infection on
pelvic inflammatory disease Obstet Gynecol 2000.95 525-34
-
Kamb ML Cervical cancer
screening of women attending sexually transmitted diseases clinics Clin
Infect Dis I995,20(Suppl 1) S98-S103
-
American Cancer Society
Guidelines for the cancer related checkup Atlanta, Georgia American Cancer
Society, 1998
-
American College of
Obstetricians and Gynecologists Routine cancer screening committee opinion
185 Washington, DC American College of Obstetricians and Gynecologists,
1997
-
National Cancer Institute
Workshop The 1988 Bethesda System for reporting cervical/vaginal
cytological diagnoses JAMA 1989 262 931-4
-
JayN, Moscich AB Human
papillomavirus infections in women with HIV disease prevalence, risk, and
management [Review] AIDS Reader 2000,10659-68
-
Kurman RJ Henson DE Herbst AL,
Noller KL, Schiffman MH, National Cancer Institute Workshop Interim
guidelines for management of abnormal cervical cytology JAMA 1994,271
1866-9
-
MacKellar DA Valleroy LA
Secura GM, et al Two decades after vac- cine license hepatitis Â
immunization and infection among young men who have sex with men Am J
Public Health 2001,91 965-71
-
CDC Immunization of
adolescents recommendations of the Advisory Committee on Immunization
Practices, the American Academy of Pediatrics the American Academy of
Family Physicians and the American Medical Association MMWR 1996 45 1-5
-
Mast ÅÅ,
Williams IT, Alter MJ, Margolis HS Hepatitis Â
vaccination of adolescent and adult high-risk groups in the United
States Vaccine 1998,16(Suppl) S27-S29
-
Alter MJ, Kruszon-Moran D,
Hainan 0V, et al The prevalence of hepatitis C virus infection in the
United States, 1988 through 1994 N Engi J Med 1999,341 556-62
-
CDC Recommendations for
prevention and control of hepatitis C virus (HCV) infection and HC\'-related
chronic disease MMWR 1998,47 (No RR-19) 1-39
-
Diegstag JL Sexual and
perinatal transmission of hepatitis C Hepatology 1997 26(Suppl 1) S66-S70
-
Alter MJ Epidemiology of
hepatitis C Hepatology 1999 26 (Suppi 1) S25-S65
-
Thomas DL, Zemlman JM Alter MJ,
et al Sexual transmission of hepatitis C virus among patients attending
Baltimore sexually transmitted disease clinics an analysis of 309 sex
partnerships J Infect Dis 1995 171 768-75
-
HisadaM, O'Bnen TR,
RosenbergPS, GoederlJJ Virus load and risk of heterosexual transmission of
human immunodeficiency virus and hepatitis C virus by men with hemophilia
the Multicenter Hemo-phiha Cohort Study J Infect Dis 2000 181 1475-8
-
BambergerJD, Waldo CR,
Gerberding JL, Katz MH Postexposure prophylaxis foi human immunodeficiency
virus (HIV) infection following sexual assault Am J Med 1999 106 323-6
-
CDC Public Health Service
guidelines for the management of health care worker exposures to HIV
and recommendations for post-exposure prophylaxis MMWR 1998,47'(No RR-7)
1-33
-
American Academy of Pediatrics
Sexually transmitted disease in adolescents and children In Pickenng LK,
ed 2000 Red book report of the Committee on Infectious Diseases 25dl ed
Elk Grove Village, IL American Academy of Pediatrics, 2000 138-47
-
American Academy of Pediatrics
Committee on Child Abuse and Neglect Guidelines for the evaluation of
sexual abuse of children subject review Pediatrics 1999 103 186-91
-
Adams JA, Harper K, Krudson S
A proposed system for the classifications of anogemtal findings in
children with suspected child abuse Adolesc Pediatr Gynecol 1992 5 73-5